Speciallægeselskabet Mavetarmklinikken Faxe ApSActive
Key figures
3.689.805 kr.-12,8%
Gross profit 2025/26
-12,8%
Average annual change 2024/25–2025/26
Key ratios
2025/26989.102 kr.
EBITDA
90,0%
Equity ratio
14×
Current ratio
20,8%
Return on equity
Balance sheet structure
Current assetsNon-current assetsLiabilities and provisionsEquity
Dividends
from the annual report2025/26
Proposed dividend for the financial year 79.400 kr. (9% of the profit for the year).
History
2025/2679.400 kr.
2024/2567.500 kr.
Proposed dividend from the annual report's profit allocation (normally paid the following year). If there is no proposal, the dividend paid according to the statement of changes in equity is shown.
Financial statements2025–2026
| 2024/25 | 2025/26 | |
|---|---|---|
| Balance sheet — assets | ||
| Cash and cash equivalents | 431.457 | 841.320 |
| Total current assets | 2.904.292 | 3.882.194 |
| Total non-current assets | 780.702 | 903.705 |
| Total assets | 3.684.994 | 4.785.899 |
| Balance sheet — liabilities and equity | ||
| Current liabilities | 204.788 | 282.434 |
| Non-current liabilities | 0 | 196.685 |
| Total liabilities | 204.788 | 479.119 |
| Share capital | 50.000 | 50.000 |
| Retained earnings of previous periods | 3.361.835 | 4.177.380 |
| Profit for the year | 278.576 | 894.945 |
| Total equity | 3.479.335 | 4.306.780 |
| Income statement | ||
| Gross profit | 4.231.993 | 3.689.805 |
| Operating profit | 148.509 | 688.231 |
| EBITDA | 715.327 | 989.102 |
| Profit before income tax | 360.081 | 1.151.977 |
| Profit for the reporting year | 278.576 | 894.945 |
| Labour costs | 3.516.666 | 2.700.703 |
| Depreciation of non-current assets | 566.818 | 300.871 |
| Other indicators | ||
| Employees | 3 | 3 |
| Dividends | 67.500 | 79.400 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
About the company
Annual report 2026Selskabets formål, er at drive speciallægevirksomhed og virksomhed naturligt forbundet hermed.
Selskabets resultatopgørelse for 2025/26 udviser et overskud på kr. 894.945, og selskabets balance pr. 30. juni 2026 udviser en egenkapital på kr. 4.306.780.
Excerpt from the management's review in the latest annual report.